Back to Search
WALTER URBA, MD, PHD
MD, PHD
Medical Oncology Physician
NPI: 1548253602Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD18449(OR)
Research & Publications (20)
Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic, cellular immunotherapy.
PMID 18801509·J Urol·2008
3-trial
Cross-presentation of tumor associated antigens through tumor-derived autophagosomes.
PMID 19333005·Autophagy·2009
8-other
Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood.
PMID 19318471·Clin Cancer Res·2009
2-rct
Phase I/II study of ipilimumab for patients with metastatic melanoma.
PMID 19018089·J Clin Oncol·2008
3-trial
Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer.
PMID 18676757·Clin Cancer Res·2008
3-trial
Efficient cross-presentation depends on autophagy in tumor cells.
PMID 18757401·Cancer Res·2008
7-preclinical
Phenotype and functional characterization of long-term gp100-specific memory CD8+ T cells in disease-free melanoma patients before and after boosting immunization.
PMID 18698047·Clin Cancer Res·2008
2-rct
Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.
PMID 18467720·J Clin Oncol·2008
3-trial
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies.
PMID 18000991·Cancer·2007
6-review
A clinical development paradigm for cancer vaccines and related biologics.
PMID 17198079·J Immunother·2007
6-review
Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain.
PMID 17374396·Mol Immunol·2007
8-other
Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans.
PMID 17395779·Blood·2007
7-preclinical
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.
PMID 17606721·Clin Cancer Res·2007
3-trial
Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model.
PMID 16772043·J Transl Med·2006
8-other
Polychromatic flow cytometry: a rapid method for the reduction and analysis of complex multiparameter data.
PMID 17089357·Cytometry A·2006
2-rct
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.
PMID 15625368·J Clin Oncol·2005
3-trial
Immunotherapy for melanoma: the good, the bad, and the future.
PMID 16091201·Curr Oncol Rep·2005
6-review
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer.
PMID 16110015·J Clin Oncol·2005
3-trial
Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.
PMID 16288050·Cancer Res·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4805 NE GLISAN ST, STE 6N40
PORTLAND, OR 97213 - Phone
- (503) 215-5696
Quick Facts
- NPI
- 1548253602
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile